No Prescription |
 |
 | ||
|
Flomax MR Generic Tamsulosin |
|
| ||
No Prescription » Prescription Drugs 7 » Flomax MR Generic Tamsulosin Product Origin: EU (Turkey) This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English. Medical Information: Tamsulosin (tam-SOO-loh-sin) is used to treat the signs and symptoms of benign enlargement of the prostate (benign prostatic hyperplasia or BPH). Benign enlargement of the prostate is a problem that can occur in men as they get older. The prostate gland is located below the bladder. As the prostate gland enlarges certain muscles in the gland may become tight and get in the way of the tube that drains urine from the bladder. This can cause problems in urinating such as a need to urinate often a weak stream when urinating or a feeling of not being able to empty the bladder completely. Tamsulosin helps relax the muscles in the prostate and the opening of the bladder. This may help increase the flow of urine and/or decrease the symptoms. However tamsulosin will not shrink the prostate. The prostate may continue to get larger. This may cause the symptoms to become worse over time. Therefore even though tamsulosin may lessen the problems caused by enlarged prostate now surgery still may be needed in the future. Flomax is used to treat the symptoms of an enlarged prostate--a condition technically known as benign prostatic hyperplasia or BPH. The walnut-sized prostate gland surrounds the urethra (the duct that drains the bladder). If the gland becomes enlarged it can squeeze the urethra interfering with the flow of urine. This can cause difficulty in starting urination a weak flow of urine and the need to urinate urgently or more frequently. Flomax doesn't shrink the prostate. Instead it relaxes the muscle around it freeing the flow of urine and decreasing urinary symptoms. Tamsulosin is in a group of drugs called alpha-adrenergic (AL-fa ad-ren-ER-jik) blockers. Tamsulosin relaxes your veins and arteries so that blood can more easily pass through them. It also relaxes the muscles in the prostate and bladder neck making it easier to urinate. Tamsulosin is used to improve urination in men with benign prostatic hyperplasia (enlarged prostate). Buy Flomax MR Generic Tamsulosin and other Prescription Drugs 7 products online at Medstore. 3669
About Flomax MR Generic Tamsulosin: Product Type: Prescription Drugs 7 Flomax MR ( Generic Tamsulosin ) Flomax MR (Generic Tamsulosin) Generic Tamsulosin 0.4mg 30 Capsules Generic Tamsulosin Flomax MR
View more Prescription Drugs 7 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
